Literature DB >> 26071398

Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.

Zhenfeng Zhang1, Shengzhe Zhang2, Pengfei Ma3, Ying Jing3, Huixin Peng3, Wei-Qiang Gao4, Guanglei Zhuang5.   

Abstract

It has been increasingly recognized that microRNAs (miRNAs) are often dysregulated in various human malignancies and can function as oncogenes or tumor-suppressors. However, the potential roles of miRNAs and components of the miRNA biogenesis pathway remain poorly defined in melanoma. Here, we systematically profiled miRNA expression in human melanocytes and melanoma cells, and identified a prominent function of miR-125a-5p in suppressing melanoma growth. Mechanistically, we discovered that Lin28B, a well-characterized inhibitor of let-7 miRNA biogenesis, was a direct target of miR-125a-5p in melanoma. We showed that the Lin28B was aberrantly expressed in a large proportion of melanoma patients and was functionally required for melanoma progression. We further demonstrated the involvement of let-7-dependent mechanism downstream of Lin28B, resulting in the activation of transforming growth factor-β signaling cascade. Collectively, our data implicate Lin28B as a novel oncogene in melanomagenesis by mediating a miRNA regulatory circuit.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26071398     DOI: 10.1093/carcin/bgv085

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.

Authors:  Nattapong Puthdee; Sira Sriswasdi; Trairak Pisitkun; Sutheera Ratanasirintrawoot; Nipan Israsena; Pisit Tangkijvanich
Journal:  Cancer Gene Ther       Date:  2021-09-21       Impact factor: 5.854

2.  miR-579-3p controls melanoma progression and resistance to target therapy.

Authors:  Luigi Fattore; Rita Mancini; Mario Acunzo; Giulia Romano; Alessandro Laganà; Maria Elena Pisanu; Debora Malpicci; Gabriele Madonna; Domenico Mallardo; Marilena Capone; Franco Fulciniti; Luca Mazzucchelli; Gerardo Botti; Carlo M Croce; Paolo Antonio Ascierto; Gennaro Ciliberto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

Review 3.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

4.  Propofol‑induced miR‑125a‑5p inhibits the proliferation and metastasis of ovarian cancer by suppressing LIN28B.

Authors:  Juan Zeng; Yu-Kun Li; Fei-Fei Quan; Xin Zeng; Chang-Ye Chen; Tian Zeng; Juan Zou; Wen-Juan Tong
Journal:  Mol Med Rep       Date:  2020-06-11       Impact factor: 2.952

5.  HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth.

Authors:  Janika K Liebig; Silke Kuphal; Anja Katrin Bosserhoff
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

6.  The lncRNA HOXA11-AS regulates Rab3D expression by sponging miR-125a-5p promoting metastasis of osteosarcoma.

Authors:  Kun Cao; Yueyang Fang; Hao Wang; Zheng Jiang; Li Guo; Yong Hu
Journal:  Cancer Manag Res       Date:  2019-05-16       Impact factor: 3.989

Review 7.  CRISPR/Cas9 and cancer targets: future possibilities and present challenges.

Authors:  Martyn K White; Kamel Khalili
Journal:  Oncotarget       Date:  2016-03-15

8.  The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.

Authors:  Dong Chen; Qiang Sun; Lufei Zhang; Xiaohu Zhou; Xiaofei Cheng; Dongkai Zhou; Feng Ye; Jianjiang Lin; Weilin Wang
Journal:  Oncotarget       Date:  2017-08-03

Review 9.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

10.  Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Authors:  Robert R J Coebergh van den Braak; Anieta M Sieuwerts; Zarina S Lalmahomed; Marcel Smid; Saskia M Wilting; Sandra I Bril; Shanshan Xiang; Michelle van der Vlugt-Daane; Vanja de Weerd; Anne van Galen; Katharina Biermann; J Han J M van Krieken; Wigard P Kloosterman; John A Foekens; John W M Martens; Jan N M IJzermans
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.